Style | Citing Format |
---|---|
MLA | Khalili H, et al.. "Meropenem/Colistin Versus Meropenem/Ampicillin-Sulbactam in the Treatment of Carbapenem-Resistant Pneumonia." Journal of Comparative Effectiveness Research, vol. 7, no. 9, 2018, pp. 901-911. |
APA | Khalili H, Shojaei L, Mohammadi M, Beigmohammadi MT, Abdollahi A, Doomanlou M (2018). Meropenem/Colistin Versus Meropenem/Ampicillin-Sulbactam in the Treatment of Carbapenem-Resistant Pneumonia. Journal of Comparative Effectiveness Research, 7(9), 901-911. |
Chicago | Khalili H, Shojaei L, Mohammadi M, Beigmohammadi MT, Abdollahi A, Doomanlou M. "Meropenem/Colistin Versus Meropenem/Ampicillin-Sulbactam in the Treatment of Carbapenem-Resistant Pneumonia." Journal of Comparative Effectiveness Research 7, no. 9 (2018): 901-911. |
Harvard | Khalili H et al. (2018) 'Meropenem/Colistin Versus Meropenem/Ampicillin-Sulbactam in the Treatment of Carbapenem-Resistant Pneumonia', Journal of Comparative Effectiveness Research, 7(9), pp. 901-911. |
Vancouver | Khalili H, Shojaei L, Mohammadi M, Beigmohammadi MT, Abdollahi A, Doomanlou M. Meropenem/Colistin Versus Meropenem/Ampicillin-Sulbactam in the Treatment of Carbapenem-Resistant Pneumonia. Journal of Comparative Effectiveness Research. 2018;7(9):901-911. |
BibTex | @article{ author = {Khalili H and Shojaei L and Mohammadi M and Beigmohammadi MT and Abdollahi A and Doomanlou M}, title = {Meropenem/Colistin Versus Meropenem/Ampicillin-Sulbactam in the Treatment of Carbapenem-Resistant Pneumonia}, journal = {Journal of Comparative Effectiveness Research}, volume = {7}, number = {9}, pages = {901-911}, year = {2018} } |
RIS | TY - JOUR AU - Khalili H AU - Shojaei L AU - Mohammadi M AU - Beigmohammadi MT AU - Abdollahi A AU - Doomanlou M TI - Meropenem/Colistin Versus Meropenem/Ampicillin-Sulbactam in the Treatment of Carbapenem-Resistant Pneumonia JO - Journal of Comparative Effectiveness Research VL - 7 IS - 9 SP - 901 EP - 911 PY - 2018 ER - |